KAYLA MEHLHAF: Open Payments
NPI 1154681880 · VIBORG, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 18 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $406 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Medtronic, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: ELIQUIS, CAPLYTA, GLASSIA, Kerendia, MINIMED 780G, JARDIANCE, NURTEC ODT, FANAPT.
Industry payments across SD — which companies pay providers there.
